Join to View Full Profile
12605 E 16th AveAurora, CO 80045
Phone+1 720-848-0000
Dr. Schenk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2014 - 2018
Clinician Investigator Training Program-, Tumor Immunology, 2014 - 2016- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
- Mayo Clinic College of MedicineClass of 2011
Certifications & Licensure
CO State Medical License 2018 - 2027
MN State Medical License 2012 - 2022
Mayo Graduate SchoolPhD
Publications & Presentations
PubMed
- Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3.Natasha B Leighl, Nofisat Ismaila, Greg Durm, Narjust Florez, Janet Freeman-Daily
Journal of Clinical Oncology. 2025-04-01 - The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitiz...Tejas Patil, Dexiang Gao, Alexander Watson, Mandy Sakamoto, Yunan Nie
Lung Cancer. 2025-01-01 - Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in No...Alexander S Watson, Harris B Krause, Andrew Elliott, Alex Farrell, Stephen V Liu
Clinical Lung Cancer. 2024-12-01
Press Mentions
Substantial Drop in Lung Cancer Deaths, Incidence, a Highlight of New Report on Cancer StatisticsApril 28th, 2025- ‘Worldwide Collaboration’ Helps Answer Questions About Lung Cancer TherapyApril 10th, 2025
- How the Immune System Affects Drug Response in Lung Cancer PatientsMay 10th, 2024
- Join now to see all
Grant Support
- Tumor Microenvironment Determinants of TKI Response in Oncogene-Driven Lung CancerUNIVERSITY OF COLORADO DENVER2024–2029
Committees
- Member, ASCO Expert Panel Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations 2022 - Present
- Member, ASCO Expert Panel Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations 2022 - Present
Professional Memberships
- Member
- Member
- International Association for the Study of Lung CancerMember
External Links
- University of Colorado School of Medicinehttps://som.cuanschutz.edu/Profiles/Faculty/Profile/27915
- UCHelathhttps://www.uchealth.org/provider/erin-schenk-md-phd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
